To Evaluate the Efficacy and Safety of Tislelizumab in Combination With Lenvatinib in Participants With Selected Solid Tumors

Clinical trial NCT05014828 · COMPLETED

Trial details

NCT number: NCT05014828
Sponsor: BeiGene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2021-09-18
Primary completion: 2023-10-20
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.